{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:46:15Z","timestamp":1793213175575,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016765","name":"Jounce Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-061093"],"award-info":[{"award-number":["AI-061093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-086037"],"award-info":[{"award-number":["AI-086037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-48693"],"award-info":[{"award-number":["AI-48693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clim.2024.110217","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T02:00:39Z","timestamp":1713060039000},"page":"110217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiency"],"prefix":"10.1016","volume":"264","author":[{"given":"Ali","family":"Sepahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-en","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapti","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Umiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Kis-Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Wiederschain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Radigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.clim.2024.110217_bb0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1542\/peds.47.5.927","article-title":"Primary immunodeficiencies. Report of a World Health Organization Committee","volume":"47","author":"Fudenberg","year":"1971","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.1994.tb06512.x","article-title":"The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency","volume":"95","author":"Fischer","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0090-1229(87)90066-3","article-title":"T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages","volume":"44","author":"Fiedler","year":"1987","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0035","first-page":"19","article-title":"Defective DNA synthesis by T cells in acquired \u2018common-variable\u2019 hypogammaglobulinaemia on stimulation with mitogens","volume":"76","author":"North","year":"1989","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110217_bb0040","first-page":"2067","article-title":"The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma","volume":"35","author":"Waldmann","year":"1976","journal-title":"Fed. Proc."},{"issue":"10","key":"10.1016\/j.clim.2024.110217_bb0045","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.144.10.3762","article-title":"Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency","volume":"144","author":"Sneller","year":"1990","journal-title":"J. Immunol."},{"issue":"4 Pt 1","key":"10.1016\/j.clim.2024.110217_bb0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0091-6749(05)80207-6","article-title":"Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency","volume":"86","author":"Adelman","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2024.110217_bb0055","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.4049\/jimmunol.170.11.5772","article-title":"Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I","volume":"170","author":"Holm","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/clin.1997.4483","article-title":"IL-10 production in common variable immunodeficiency","volume":"86","author":"Zhou","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/eji.1830260136","article-title":"Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency","volume":"26","author":"Fischer","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110217_bb0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.clim.2024.110217_bb0075","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/blood-2009-02-207423","article-title":"Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency","volume":"114","author":"Borte","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2024.110217_bb0085","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0091-6749(03)02021-9","article-title":"Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis","volume":"112","author":"Lee","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6816","key":"10.1016\/j.clim.2024.110217_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35051107","article-title":"ICOS is critical for CD40-mediated antibody class switching","volume":"409","author":"McAdam","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clim.2024.110217_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3389\/fimmu.2017.00964","article-title":"14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency","volume":"8","author":"Schepp","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.coi.2010.01.001","article-title":"Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)","volume":"22","author":"Simpson","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0105","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.177.6.3920","article-title":"Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein","volume":"177","author":"Chattopadhyay","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2024.110217_bb0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110217_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (Tfh)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2024.110217_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/tan.13671","article-title":"The role of follicular T helper cells in the humoral alloimmune response after clinical organ transplantation","volume":"94","author":"van Besouw","year":"2019","journal-title":"Hla"},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/14712598.2020.1693540","article-title":"Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy","volume":"20","author":"Amatore","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000544","article-title":"The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy","volume":"5","author":"Solinas","year":"2020","journal-title":"ESMO Open."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2020.1776079","article-title":"T follicular helper cell subsets: a potential key player in autoimmunity","volume":"44","author":"Kurata","year":"2021","journal-title":"Immunol. Med."},{"key":"10.1016\/j.clim.2024.110217_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fimmu.2020.00006","article-title":"Functions of Tfh cells in common variable immunodeficiency","volume":"11","author":"Le Saos-Patrinos","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110217_bb0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clim.2018.09.006","article-title":"Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications","volume":"197","author":"Turpin","year":"2018","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41573-019-00214-5","article-title":"Immune agonist antibodies face critical test","volume":"19","author":"Garber","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.clim.2024.110217_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239595","article-title":"ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models","volume":"15","author":"Hanson","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110217_bb0165","series-title":"First-in-Human Phase I\/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response","author":"Yap","year":"2022"},{"key":"10.1016\/j.clim.2024.110217_bb0170","article-title":"181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V)+ pimivalimab (P) vs P in TISvopra selected patients (pts)","volume":"vol. 16","author":"Gumus","year":"2022","journal-title":"Immuno-Oncol. Technol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0175","first-page":"38","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2024.110217_bb0180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ni.3494","article-title":"Activin A programs the differentiation of human TFH cells","volume":"17","author":"Locci","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/icb.2013.55","article-title":"Human T follicular helper (Tfh) cells and disease","volume":"92","author":"Ma","year":"2014","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clim.2024.110217_bb0200","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/eji.202149480","article-title":"Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency","volume":"52","author":"Milardi","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/iid3.326","article-title":"Phenotypically defined subpopulations of circulating follicular helper T cells in common variable immunodeficiency","volume":"8","author":"Yesillik","year":"2020","journal-title":"Immun. Inflamm. Dis."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The T(H)1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency","volume":"141","author":"Unger","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110217_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fimmu.2017.00174","article-title":"Follicular T cells from smB(\u2212) common variable immunodeficiency patients are skewed toward a Th1 phenotype","volume":"8","author":"Cunill","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular helper T cells in immunity and systemic autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7502","key":"10.1016\/j.clim.2024.110217_bb0225","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal Centre by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.clim.2024.110217_bb0230","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q","article-title":"Induction, binding specificity and function of human ICOS","volume":"30","author":"Beier","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"6716","key":"10.1016\/j.clim.2024.110217_bb0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/16717","article-title":"ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28","volume":"397","author":"Hutloff","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.imlet.2006.02.007","article-title":"CD28 and ICOS: similar or separate costimulators of T cells?","volume":"105","author":"Van Berkel","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2024.110217_bb0245","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fimmu.2016.00304","article-title":"ICOS co-stimulation: friend or foe?","volume":"7","author":"Wikenheiser","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.immuni.2015.01.017","article-title":"ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation","volume":"42","author":"Stone","year":"2015","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ni.1690","article-title":"Costimulatory molecule ICOS plays a critical role in the development of TH-17 and follicular T-helper cells by regulating c-Maf expression and IL-21 production","volume":"10","author":"Bauquet","year":"2009","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2024.110217_bb0260","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.177.7.4927","article-title":"ICOS deficiency is associated with a severe reduction of CXCR5+ CD4 germinal center Th cells","volume":"177","author":"Bossaller","year":"2006","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110217_bb0265","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","article-title":"Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration","volume":"179","author":"Kuchen","year":"2007","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2024.110217_bb0270","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.4049\/jimmunol.170.11.5772","article-title":"Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency\u2013involvement of protein kinase a type I","volume":"170","author":"Holm","year":"2003","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.clim.2024.110217_bb0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144777","article-title":"Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency","volume":"6","author":"Ho","year":"2021","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.clim.2024.110217_bb0280","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02289-w","article-title":"Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases","volume":"18","author":"Zhou","year":"2020","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/2049-632X.12034","article-title":"IgG subclass profiles in normal human sera of antibodies specific to five kinds of microbial antigens","volume":"67","author":"Hjelholt","year":"2013","journal-title":"Pathog. Dis."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0295","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0300","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.immuni.2008.05.001","article-title":"The biology of intestinal immunoglobulin a responses","volume":"28","author":"Cerutti","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nri.2015.17","article-title":"Mucosal immunity to pathogenic intestinal bacteria","volume":"16","author":"Perez-Lopez","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2024.110217_bb0310","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/clin.1996.0132","article-title":"Development of a common variable immunodeficiency in IgA-deficient patients","volume":"80","author":"Espanol","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","article-title":"Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)","volume":"120","author":"Hammarstr\u00f6m","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2024.110217_bb0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000501457","article-title":"Phenotypic analysis of CD4+ Treg, CD8+ Treg, and breg cells in adult common variable immunodeficiency patients","volume":"180","author":"Yesillik","year":"2019","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110217_bb0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5+ CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110217_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576724","article-title":"Immune monitoring of patients with primary immune regulation disorders unravels higher frequencies of follicular T cells with different profiles that associate with alterations in B cell subsets","volume":"11","author":"Caldirola","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110217_bb0335","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2019.08.007","article-title":"Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage","volume":"144","author":"Le Coz","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110217_bb0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2024.110217_bb0345","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood-2005-07-2955","article-title":"Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency","volume":"107","author":"Warnatz","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clim.2024.110217_bb0350","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.4049\/jimmunol.175.8.5498","article-title":"Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients","volume":"175","author":"Taubenheim","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110217_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074893","article-title":"Interferon signature in the blood in inflammatory common variable immune deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T01:21:16Z","timestamp":1738459276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":71,"alternative-id":["S1521661624001086"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110217","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110217"}}